A pharmaceutical company focused on advancement of unmet vaccines against viruses that cause serious human diseases such as respiratory syncytial virus (RSV). Meissa Vaccines applies their platform technology for viral genetic engineering to multiple pathogens.
5
Funding Rounds
$72.3m
Money raised
Access comprehensive data and insights available only to Seedtable members
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Name | Phone | Social networks | |
---|---|---|---|
Ro****** Ta** |
|
- | - |
Ma*** Mo*** |
|
- |